miR-499 Ameliorates Podocyte Injury by Targeting Calcineurin in Minimal Change Disease.

CONCLUSIONS: MiR-499 ameliorated podocyte injury by targeting CnAα and CnAβ in a PAN-induced MCD mouse model. Delivery of miR-499 can be a novel strategy for MCD treatment.
PMID: 29448244 [PubMed - as supplied by publisher]

Source: American Journal of Nephrology - February 15, 2018 Category: Urology & Nephrology Authors: Zhang K, Sun W, Zhang L, Xu X, Wang J, Hong Y Tags: Am J Nephrol Source Type: research